Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Akihiro Nakajima, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kurihara O, Takano M, Soeda T, Fracassi F, Araki M, Nakajima A, McNulty I, Lee H, Mizuno K, Jang IK. Degree of luminal narrowing and composition of thrombus in plaque erosion. J Thromb Thrombolysis. 2020 May 29. PMID: 32472306.
    Citations:    
  2. Nakajima A, Mitomo S, Demir OM, Nakamura S. Sneaking hematoma beyond the stent implanted for focal stenosis of the right coronary artery: insight from intravascular ultrasound. Kardiol Pol. 2020 May 26. PMID: 32458672.
    Citations:    
  3. Warisawa T, Cook CM, Rajkumar C, Howard JP, Seligman H, Ahmad Y, El Hajj S, Doi S, Nakajima A, Nakayama M, Goto S, Vera-Urquiza R, Sato T, Kikuta Y, Kawase Y, Nishina H, Petraco R, Al-Lamee R, Nijjer S, Sen S, Nakamura S, Lerman A, Matsuo H, Francis DP, Akashi YJ, Escaned J, Davies JE. Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave-Free Ratio Evaluation. JACC Cardiovasc Interv. 2020 May 08. PMID: 32417088.
    Citations:    
  4. Kurihara O, Shinohara H, Kim HO, Russo M, Araki M, Nakajima A, Lee H, Takano M, Mizuno K, Komuro I, Jang IK. Comparison of post-stent optical coherence tomography findings: Layered versus non-layered culprit lesions. Catheter Cardiovasc Interv. 2020 Apr 25. PMID: 32333723.
    Citations:    
  5. Warisawa T, Cook CM, Seligman H, Howard JP, Ahmad Y, Rajkumar C, Doi S, Nakayama M, Tanigaki T, Omori H, Nakajima A, Yamanaka F, Goto S, Yakuta Y, Karube K, Uetani T, Kikuta Y, Shiono Y, Kawase Y, Nishina H, Nakamura S, Escaned J, Akashi YJ, Matsuo H, Davies JE. Per-Vessel Level Analysis of Fractional Flow Reserve and Instantaneous Wave-Free Ratio Discordance - Insights From the AJIP Registry. Circ J. 2020 May 25; 84(6):1034-1038. PMID: 32321880.
    Citations:    
  6. Nakajima A, Araki M, Kurihara O, Minami Y, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Lee H, Nakamura S, Jang IK. Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome. Catheter Cardiovasc Interv. 2020 Mar 17. PMID: 32181576.
    Citations:    
  7. Hatano Y, Sugai A, Yamagishi T, Nakajima A, Kakita A, Onodera O. [Amyloid ß-related angiitis presenting extensive brain involvement without detection of hemorrhagic lesions: A case report]. Rinsho Shinkeigaku. 2020 Mar 31; 60(3):187-192. PMID: 32101841.
    Citations:    
  8. Asano K, Sagara H, Ichinose M, Hirata M, Nakajima A, Ortega H, Tohda Y. A Phase 2a Study of DP2 Antagonist GB001 for Asthma. J Allergy Clin Immunol Pract. 2020 Apr; 8(4):1275-1283.e1. PMID: 31778823.
    Citations:    
  9. Nakajima A, Hozawa K, Nakamura S. Successful Repair of a Deep Femoral Artery Injury Caused by Femoral Trochanteric Fracture Surgery Using a Polytetrafluoroethylene-Covered Stent. JACC Cardiovasc Interv. 2019 04 22; 12(8):796-797. PMID: 30928444.
    Citations:    
  10. Nakajima A, Tanaka K, Nakamura S. 2-Year follow-up of a patient with CD36 deficiency and takotsubo cardiomyopathy. J Nucl Cardiol. 2020 Feb; 27(1):330-332. PMID: 30187241.
    Citations:    
  11. Yabushita H, Kawamoto H, Fujino Y, Tahara S, Horikoshi T, Tada M, Amano T, Onishi H, Nakajima A, Warisawa T, Watanabe Y, Yoshizaki T, Mitomo S, Sato T, Naganuma T, Ishiguro H, Kurita N, Nakamura S, Hozawa K, Nakamura S. Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers. Circ Cardiovasc Interv. 2018 08; 11(8):e005935. PMID: 30354780.
    Citations:    
  12. Nakajima A, Kawamoto H, Nakao T, Nakamura S. ST-segment elevation myocardial infarction caused by aortic pseudoaneurysm following surgical mitral valvuloplasty. Eur J Cardiothorac Surg. 2018 07 01; 54(1):189-190. PMID: 29351599.
    Citations:    
  13. Nakajima A, Kawamoto H, Nakamura S, Tresukosol D. One-year imaging follow-up of a self-expanding bifurcation drug-eluting stent and bioresorbable scaffold for a complex bifurcation lesion. Coron Artery Dis. 2018 06; 29(4):354-356. PMID: 29076827.
    Citations:    
  14. Nakajima A, Matsuura N, Mukai K, Yamanishi K, Yamada H, Maebayashi K, Hayashida K, Matsunaga H. Ten-year follow-up study of Japanese patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2018 Jul; 72(7):502-512. PMID: 29652103.
    Citations:    
  15. Mitomo S, Jabbour RJ, Watanabe Y, Mangieri A, Ancona M, Regazzoli D, Tanaka A, Nakajima A, Naganuma T, Giannini F, Latib A, Nakamura S, Colombo A. Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: Insights from an international multicenter registry. Int J Cardiol. 2018 03 01; 254:53-58. PMID: 29407132.
    Citations:    
  16. Ito T, Honma Y, Hijioka S, Kudo A, Fukutomi A, Nozaki A, Kimura Y, Motoi F, Isayama H, Komoto I, Hisamatsu S, Nakajima A, Shimatsu A. Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors. Invest New Drugs. 2017 08; 35(4):499-508. PMID: 28470558.
    Citations:    
  17. Mukai K, Matsuura N, Nakajima A, Yanagisawa Y, Yoshida Y, Maebayashi K, Hayashida K, Matsunaga H. Evaluations of hemodynamic changes during neuropsychological test batteries using near-infrared spectroscopy in patients with obsessive-compulsive disorder. Psychiatry Res Neuroimaging. 2017 04 30; 262:1-7. PMID: 28189045.
    Citations:    
  18. Warisawa T, Ishiguro H, Nakajima A, Nakamura S. Novel "baby-in-mother" technique with the GuideLiner in the bifurcation coronary intervention with the protect-wire kept in the side branch. Cardiovasc Interv Ther. 2017 Jul; 32(3):254-258. PMID: 27277536.
    Citations:    
  19. Saeki T, Nakajima A, Ito T, Takata T, Imai N, Yoshita K, Kabasawa H, Yamazaki H, Narita I. Tubulointerstitial nephritis and Fanconi syndrome in a patient with primary Sjögren's syndrome accompanied by antimitochondrial antibodies: A case report and review of the literature. Mod Rheumatol. 2018 Sep; 28(5):897-900. PMID: 27142563.
    Citations:    
  20. Tamura K, Kawai Y, Kiguchi T, Okamoto M, Kaneko M, Maemondo M, Gemba K, Fujimaki K, Kirito K, Goto T, Fujisaki T, Takeda K, Nakajima A, Ueda T. Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol. Int J Clin Oncol. 2016 Oct; 21(5):996-1003. PMID: 27017611.
    Citations:    
  21. Yanagisawa Y, Matsuura N, Mukai K, Nakajima A, Motoyama M, Yamanishi K, Yamada H, Hayashida K, Matsunaga H. Clinically related or predictive factors and impacts on long-term treatment outcomes of involvement behaviors in patients with obsessive-compulsive disorder. Compr Psychiatry. 2015 Jul; 60:105-13. PMID: 25861961.
    Citations:    
  22. Mito H, Matsuura N, Mukai K, Yanagisawa Y, Nakajima A, Motoyama M, Arikawa A, Yamanishi K, Matsunaga H. The impacts of elevated autism spectrum disorder traits on clinical and psychosocial features and long-term treatment outcome in adult patients with obsessive-compulsive disorder. Compr Psychiatry. 2014 Oct; 55(7):1526-33. PMID: 24957957.
    Citations:    
  23. Nakamura H, Yokoyama H, Takayanagi R, Yoshimoto K, Nakajima A, Okuyama K, Iwase O, Yamada Y. Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin. Eur J Drug Metab Pharmacokinet. 2015 Mar; 40(1):39-44. PMID: 24470169.
    Citations:    
  24. Nakamura H, Yokoyama H, Yoshimoto K, Nakajima A, Okuyama K, Iwase O, Yamada Y. Method for individualized evaluation of antiemetic effect induced by 5-HT3 receptor antagonist. Biol Pharm Bull. 2013; 36(5):780-7. PMID: 23459393.
    Citations:    
  25. Okabe S, Tauchi T, Nakajima A, Sashida G, Gotoh A, Broxmeyer HE, Ohyashiki JH, Ohyashiki K. Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis. Stem Cells Dev. 2007 Jun; 16(3):503-14. PMID: 17610380.
    Citations:    
  26. Ishii Y, Sashida G, Takaku TI, Sumi M, Nakajima A, Ohyashiki K. Cryptic chromosomal anomaly in a patient with acute myeloid leukemia leading to AML1/ETO fusion with unfavorable prognostic factors. Cancer Genet Cytogenet. 2005 Jul 01; 160(1):94-5. PMID: 15949579.
    Citations:    
  27. Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy. Haematologica. 2003 Nov; 88(11):EIM13. PMID: 14607766.
    Citations:    
  28. Tauchi T, Sumi M, Nakajima A, Sashida G, Shimamoto T, Ohyashiki K. BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells. Clin Cancer Res. 2003 Sep 15; 9(11):4267-73. PMID: 14519654.
    Citations:    
  29. Kubota N, Miyazawa K, Shoji N, Sumi M, Nakajima A, Kimura Y, Oshiro H, Ebihara Y, Ohyashiki K. A massive intraventricular thrombosis by disseminated mucormycosis in a patient with myelodysplastic syndrome during deferoxamine therapy. Haematologica. 2003 Sep; 88(9):EIM11. PMID: 12969824.
    Citations:    
  30. Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH, Ohyashiki K. Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene. 2003 Aug 14; 22(34):5338-47. PMID: 12917635.
    Citations:    
  31. Shimamoto T, Nakajima A, Katagiri T, Ito Y, Ohyashiki K. Myeloid/natural killer cell precursor acute leukemia accompanied by homozygous protein C deficiency. Int J Hematol. 2003 Aug; 78(2):149-53. PMID: 12953810.
    Citations:    
  32. Sashida G, Ohyashiki JH, Nakajima A, Sumi M, Kawakubo K, Tauchi T, Ohyashiki K. Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases. Clin Cancer Res. 2003 Apr; 9(4):1489-96. PMID: 12684424.
    Citations:    
  33. Nakajima A, Tauchi T, Sumi M, Bishop WR, Ohyashiki K. Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells. Mol Cancer Ther. 2003 Mar; 2(3):219-24. PMID: 12657715.
    Citations:    
  34. Sashida G, Ito Y, Nakajima A, Kawakubo K, Kuriyama Y, Yagasaki F, Bessho M, Ohyashiki K. Multiple myeloma with monosomy 13 developed in trisomy 13 acute myelocytic leukemia: numerical chromosome abnormality during chromosomal segregation process. Cancer Genet Cytogenet. 2003 Mar; 141(2):154-6. PMID: 12606134.
    Citations:    
  35. Sumi M, Tauchi T, Sashida G, Kuriyama Y, Nakajima A, Mukai K, Ohyashiki K. Natural killer cell lymphoma in the duodenum. Leuk Lymphoma. 2003 Jan; 44(1):201-4. PMID: 12691165.
    Citations:    
  36. Misawa M, Tauchi T, Sashida G, Nakajima A, Abe K, Ohyashiki JH, Ohyashiki K. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol. 2002 Nov; 21(5):1087-92. PMID: 12370759.
    Citations:    
  37. Tauchi T, Nakajima A, Sashida G, Shimamoto T, Ohyashiki JH, Abe K, Yamamoto K, Ohyashiki K. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells. Clin Cancer Res. 2002 Nov; 8(11):3341-7. PMID: 12429620.
    Citations:    
  38. Sumi M, Tauchi T, Shimamoto T, Sshida G, Nakajima A, Ito Y, Ohyashiki K. [Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy]. Rinsho Ketsueki. 2002 Sep; 43(9):868-70. PMID: 12412295.
    Citations:    
  39. Kuriyama Y, Nakajima A, Shimizu N, Ohyashiki JH, Mukai K, Ohyashiki K. Detection of Epstein-Barr virus in a pyothorax-associated lymphoma with T-cell phenotype. Haematologica. 2002 Aug; 87(8):ECR28. PMID: 12161375.
    Citations:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Nakajima's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (220)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.